Followers | 246 |
Posts | 2992 |
Boards Moderated | 1 |
Alias Born | 06/16/2015 |
Tuesday, December 08, 2020 1:53:13 AM
Here's a brief summary of the AVXL case example R/S and Nasdaq uplift from OTCQX in 2015 -
The company began planning for it at the beginning of the year (2015) when the pre-split price was in the range of $.15 to $.20. The price grew all year long and by the time of the formal reverse split announcement in early October, was in the range of $1.50 to $2.00 pre-split. The split was 1-for-4 and was effective the very next day after the announcement, when the stock initially dropped to close at about $5.80 ($1.45 pre-split) from the prior day's close of $7.60 ($1.90 pre-split). So it lost about 23% that day. The price then totally recovered after 1 day, and further rallied to a high of $15 just a few days after the Nasdaq listing became effective, about 3 weeks later.
So... correlating where we are today with RXMD, AVXL was in the range of pps= .15 to .20 when plans were initiated for the Nasdaq uplisting. The stock price then ran over 8-9 months to roughly 10x the initial value just prior to the R/S, and then doubled again over the next 20 days, setting up for the first days of trading on Nasdaq.
(refer to the charts below)
(AVXL press releases with final/formal announcement of R/S and also NASDAQ listing follow the charts below)
AVXL did then pull back, as most do after IPO, but settled solidly into the $6 to $8 range, which was still multiples of the original price. The price is STILL around $4 to $6, still trading on Nasdaq, and the company is doing very well. Very well, in fact, for a biotech that STILL has ZERO REVENUE. RXMD has MUCH revenue and is growing rapidly! And can do so more effectively and with access to much higher quality funding when on a national stock exchange!
https://www.anavex.com/anavex-prepares-for-uplisting-to-nasdaq-announces-reverse-stock-split/
https://www.anavex.com/anavex-announces-uplisting-to-nasdaq/
https://www.anavex.com/anavex-commences-trading-on-nasdaq-today-to-ring-fridays-closing-bell/
Chart:
https://www.stockscores.com/chart.asp?TickerSymbol=AVXL&TimeRange=10000&Interval=m&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=BB&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=RSI&Indicator2=AccDist&Indicator3=SStoch&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
Recent RXMD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 07:54:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 04:38:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 04:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:40:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:34:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:20:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:04:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:40:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:37:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:35:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 04:14:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:54:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:51:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:49:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 07:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 09:34:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 09:33:46 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM